ESG

B Corp KnowledgeOwl partners with Rainforest Trust, letting customers decide which endangered species and habitats their software helps save. A new model for tech.

Pioneering period care brand Natracare rejects corporate buyouts, transitioning to an Employee Ownership Trust to permanently protect its ethical mission.

Shimadzu renews critical seismic certification for its X-ray systems, blending disaster resilience with smart imaging tech for California's hospitals.

Healthcare powerhouse Terri Cooper joins Morphic Medical's board, a strategic move to navigate clinical trials for its non-surgical RESET diabetes therapy.

A new RNA drug shows promise by reducing harmful belly fat while preserving muscle, but modest overall weight loss in early trials spooks investors.

Early trial data for tazbentetol shows promise in treating schizophrenia by rebuilding synapses, a potential paradigm shift in psychiatric medicine.

A new partnership between Boehringer Ingelheim and the CT Science Center seeks to build a talent pipeline for the state's booming biopharma industry.

China Mobile's new Global Intelligence Center in Hong Kong aims to supercharge the city's AI sector and serve as a key node in Beijing's global ambitions.

Italy's top fashion retailer OVS launches its second Indian store in Mumbai, signaling a major push into the nation's competitive apparel market.

A breakthrough rollable solar wing promises to slash satellite costs by 90%, accelerating the LEO boom and bringing space-grade tech down to Earth.

As AI pushes Canada's grid to the brink, a firm pivots from steel to hydrogen, joining an alliance to solve the data centre energy crisis.

Despite revenue growth, ICAPE Group posts a net loss after deciding to close two plants, signaling a pivot to a leaner model focused on innovation.

The world's top gift fair in Shenzhen showcases a new era of giving, where AI gadgets and sustainable packaging are no longer a niche, but the new standard.

With 85% of business travelers extending trips for leisure, Vietnam's coastal city is booming. See how resorts are adapting to the new work-play reality.

The company's B-cell cancer assay has achieved stringent IVDR certification, navigating a complex landscape and gaining a key edge in Europe's market.

Armata Pharmaceuticals posts a staggering $174M annual loss, triggering a 'going concern' alert, yet its promising phage therapy pipeline advances.

Fueled by a $250K grant from Allen Family Philanthropies, a new pilot aims to tackle Seattle's infamous social isolation with a structured national plan.

A new high-tech wellness center arrives in Boulder, offering cutting-edge services. But does the science support the high price of proactive health?

A federal judge's ruling allows a lawsuit to proceed over an alleged $2.2B valuation gap, placing the secretive world of corporate appraisal under a microscope.

The famed Japanese V60 maker expands beyond equipment, launching a premium organic ceremonial matcha crafted exclusively for the booming U.S. market.